SCHEMBL821949

SCHEMBL821949

CC(CO)OC(=O)C(O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.47
MAPK1 P28482 1/20 0.47
KMT2A Q03164 1/20 0.46
POLB P06746 1/20 0.44
HPGD P15428 1/20 0.43
CES2 O00748 1/20 0.43
CES1 P23141 1/20 0.43
HSD17B10 Q99714 2/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
TSHR P16473 1/20 0.42
ALDH1A1 P00352 1/20 0.42
CHRM2 P08172 2/20 0.41
CHRM1 P11229 2/20 0.41
CHRM4 P08173 1/20 0.41
CHRM5 P08912 1/20 0.41
CHRM3 P20309 1/20 0.41
BLM P54132 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17766275 0.86 MAPT (0.54) LMNAMAPK1KMT2APOLBHPGD
SCHEMBL4485798 0.82 LMNA (0.54) LMNAMAPK1KMT2AHPGDCES2
SCHEMBL4485794 0.82 LMNA (0.54) LMNAMAPK1KMT2AHPGDCES2
SCHEMBL27644882 0.80 CRHBP (0.49) LMNAKMT2APOLBHSD17B10ALDH1A1
SCHEMBL30146834 0.77 LMNA (0.48) LMNAMAPK1KMT2APOLBHPGD
SCHEMBL9312069 0.77 TSHR (0.51) LMNAMAPK1KMT2AHPGDCES2
SCHEMBL4014858 0.76 LMNA (0.47) LMNAMAPK1KMT2AHPGDCES2
SCHEMBL28469111 0.76 LMNA (0.47) LMNAMAPK1KMT2AHPGDCES2
SCHEMBL5898749 0.76 LMNA (0.56) LMNAMAPK1KMT2AHPGDCES2
SCHEMBL9163095 0.76 LMNA (0.56) LMNAMAPK1KMT2AHPGDCES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110287102-A1 CHAIN EXTENDERS POLYNOVO BIOMATERIALS PTY LIMITED (AU) 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110287102-A1 CHAIN EXTENDERS UMPS, PUF60, SMCHD1 LMNA 570/4885MAPK1 1917/4885KMT2A 3905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.